438219-08-0

Basic information

• Product Name: 5-[(4-chlorophenoxy)methyl]-2-furaldehyde
• Synonyms: 5-[(4-chlorophenoxy)methyl]-2-furaldehyde
• CAS NO: 438219-08-0
• Molecular Formula: C12H9ClO3
• Molecular Weight: 236.65106
• Mol File: 438219-08-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-[(4-chlorophenoxy)methyl]-2-furaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 5-[(4-chlorophenoxy)methyl]-2-furaldehyde(438219-08-0)
• EPA Substance Registry System: 5-[(4-chlorophenoxy)methyl]-2-furaldehyde(438219-08-0)

Safety Data

• Hazardous Substances Data: 438219-08-0(Hazardous Substances Data)

Relevant articles and documents

PRODRUG AND PROTECTED FORMS OF 5-HYDROXYMETHYLFURFURANAL (5-HMF) AND ITS DERIVATIVES

Prodrugs and derivatives of 5-hydoxymethyl-2-furfural (5-HMF) with protected or modified aldehyde and/or alcohol moieties are provided. The prodrugs or derivatives exhibit increased bioavailability, e.g. due to having extended half-lives in circulation. The drugs are therefore administered i) at lower doses and/or ii) less frequently than 5-HMF, while still maintaining the beneficial therapeutic effects of 5-HMF.

FURAN DERIVATIVES FOR PREVENTING AND CURING OSTEOPOROSIS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

The present invention relates to furan derivatives and pharmaceutical compositions containing them to prevent and cure osteoporosis. The furan derivatives of the present invention have effect on bone proliferation with the side effect reduced, so that they can be used for bone disease.

2 - SUBSTITUTED HETEROCYCLIC COMPOUNDS AND ANTITUMOR COMPOSITION COMPRISING THE SAME

The present invention relates with 2-substituted heterocyclic compounds and antitumor composition comprising the same. The compound according to the present invention exhibits superior effect as telomerase inhibitor based on new mechanism (terlomere-terlomerase) which can resolve the problems occurring at the time of using chemotherapeutics, i.e side effects and cross resistance between related mechanism on using chemotherapeutics. In addition, the antitumor composition comprising the compound of the present invention exhibits superior effect in inhibiting the growth of cancer cell.

FURAN DERIVATIVES FOR PREVENTING AND CURING OSTEOPOROSIS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

The present invention relates to furan derivatives and pharmaceutical compositions containing them to prevent and cure osteoporosis. The furan derivatives of the present invention have effect on bone proliferation with the side effect reduced, so that they can be used for bone disease.